Current management of Alström syndrome and recent advances in treatment
Authors:
- 2 June 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Orphan Drugs
- Vol. 4 (7) , 747-759
Abstract
Introduction: Alström syndrome is a recessively inherited condition (OMIM 203800) characterised by dual sensory loss, type 2 diabetes, coronary artery disease, organ fibrosis, and smooth muscle dysfunction. Areas covered: This paper covers family support, educational needs, cardiomyopathy, blindness, deafness, metabolic syndrome, diabetes, smooth muscle dysfunction, hepatic and renal fibrosis. Sources of data include multidisciplinary clinic audits, a research database, Alström Syndrome International clinics, PubMed and Embase searches. Expert opinion: A single intervention to prevent or reverse all manifestations of Alström syndrome is not currently possible. Multidisciplinary annual review is essential to plan treatments and intervene early to treat complications. Braille, IT skills and digital hearing aids are crucial to support education and social integration. Lifestyle modification will prevent type 2 diabetes and mitigate metabolic syndrome and coronary artery disease. Renal transplantation is safe. Hepatic cirrhosis, oesophageal reflux and bladder dystonia are treated as in the general population. Multiple organ dysfunction confers a high risk of death from pneumonia and post-operative hypoxia. Therefore influenza and pneumococcus vaccinations are strongly recommended. Intensive care after all invasive procedures and for infant cardiomyopathy is crucial. Exploration of new therapies to slow retinal degeneration and organ fibrosis is at an early stage.Keywords
Funding Information
- Lottery Science Grant (10/HO203)
This publication has 68 references indexed in Scilit:
- The clinical utility of C‐peptide measurement in the care of patients with diabetesDiabetic Medicine, 2013
- Brain involvement in Alström syndromeOrphanet Journal of Rare Diseases, 2013
- Coronary artery disease in Alström syndromeEuropean Journal of Human Genetics, 2011
- The progression from obesity to type 2 diabetes in Alström syndromePediatric Diabetes, 2011
- Clinical utility gene card for: Alström syndromeEuropean Journal of Human Genetics, 2011
- Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarityHuman Molecular Genetics, 2010
- 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes StudyThe Lancet, 2009
- Cardiac magnetic resonance imaging in Alström syndromeOrphanet Journal of Rare Diseases, 2009
- Caloric restriction in Alström syndrome prevents hyperinsulinemiaAmerican Journal of Medical Genetics Part A, 2009
- Alstrom syndrome (OMIM 203800): a case report and literature reviewOrphanet Journal of Rare Diseases, 2007